Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line.

Adey A, Burton JN, Kitzman JO, Hiatt JB, Lewis AP, Martin BK, Qiu R, Lee C, Shendure J.

Nature. 2013 Aug 8;500(7461):207-11. doi: 10.1038/nature12064.

2.

Integrated HPV genomes tend to integrate in gene desert areas in the CaSki, HeLa, and SiHa cervical cancer cell lines.

Diao MK, Liu CY, Liu HW, Li JT, Li F, Mehryar MM, Wang YJ, Zhan SB, Zhou YB, Zhong RG, Zeng Y.

Life Sci. 2015 Apr 15;127:46-52. doi: 10.1016/j.lfs.2015.01.039. Epub 2015 Mar 5.

PMID:
25747255
3.

HeLa nucleic acid contamination in the cancer genome atlas leads to the misidentification of human papillomavirus 18.

Cantalupo PG, Katz JP, Pipas JM.

J Virol. 2015 Apr;89(8):4051-7. doi: 10.1128/JVI.03365-14. Epub 2015 Jan 28.

4.

Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing.

Liang WS, Aldrich J, Nasser S, Kurdoglu A, Phillips L, Reiman R, McDonald J, Izatt T, Christoforides A, Baker A, Craig C, Egan JB, Chase DM, Farley JH, Bryce AH, Stewart AK, Borad MJ, Carpten JD, Craig DW, Monk BJ.

Int J Gynecol Cancer. 2014 Feb;24(2):329-38. doi: 10.1097/IGC.0000000000000049.

5.

Unscheduled DNA replication origin activation at inserted HPV 18 sequences in a HPV-18/MYC amplicon.

Conti C, Herrick J, Bensimon A.

Genes Chromosomes Cancer. 2007 Aug;46(8):724-34.

PMID:
17444495
6.

DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.

Melsheimer P, Vinokurova S, Wentzensen N, Bastert G, von Knebel Doeberitz M.

Clin Cancer Res. 2004 May 1;10(9):3059-63.

7.

The genomic and transcriptomic landscape of a HeLa cell line.

Landry JJ, Pyl PT, Rausch T, Zichner T, Tekkedil MM, Stütz AM, Jauch A, Aiyar RS, Pau G, Delhomme N, Gagneur J, Korbel JO, Huber W, Steinmetz LM.

G3 (Bethesda). 2013 Aug 7;3(8):1213-24. doi: 10.1534/g3.113.005777.

8.

Epigenetics of human papillomaviruses.

Johannsen E, Lambert PF.

Virology. 2013 Oct;445(1-2):205-12. doi: 10.1016/j.virol.2013.07.016. Epub 2013 Aug 13.

9.

Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes.

Strong MJ, Baddoo M, Nanbo A, Xu M, Puetter A, Lin Z.

J Virol. 2014 Sep;88(18):10696-704. doi: 10.1128/JVI.01457-14. Epub 2014 Jul 2.

10.

Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism.

Hu Z, Zhu D, Wang W, Li W, Jia W, Zeng X, Ding W, Yu L, Wang X, Wang L, Shen H, Zhang C, Liu H, Liu X, Zhao Y, Fang X, Li S, Chen W, Tang T, Fu A, Wang Z, Chen G, Gao Q, Li S, Xi L, Wang C, Liao S, Ma X, Wu P, Li K, Wang S, Zhou J, Wang J, Xu X, Wang H, Ma D.

Nat Genet. 2015 Feb;47(2):158-63. doi: 10.1038/ng.3178. Epub 2015 Jan 12.

PMID:
25581428
11.

Genomic organization of amplified MYC genes suggests distinct mechanisms of amplification in tumorigenesis.

Herrick J, Conti C, Teissier S, Thierry F, Couturier J, Sastre-Garau X, Favre M, Orth G, Bensimon A.

Cancer Res. 2005 Feb 15;65(4):1174-9.

13.

Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13.

Ferber MJ, Eilers P, Schuuring E, Fenton JA, Fleuren GJ, Kenter G, Szuhai K, Smith DI, Raap AK, Brink AA.

Cancer Genet Cytogenet. 2004 Oct 1;154(1):1-9.

PMID:
15381365
14.

Long-distance interaction of the integrated HPV fragment with MYC gene and 8q24.22 region upregulating the allele-specific MYC expression in HeLa cells.

Shen C, Liu Y, Shi S, Zhang R, Zhang T, Xu Q, Zhu P, Chen X, Lu F.

Int J Cancer. 2017 May 3. doi: 10.1002/ijc.30763. [Epub ahead of print]

PMID:
28470669
15.

Landscape of genomic alterations in cervical carcinomas.

Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B, Romero-Cordoba S, Treviño V, Vazquez-Santillan K, Guadarrama AS, Wright AA, Rosenberg MW, Duke F, Kaplan B, Wang R, Nickerson E, Walline HM, Lawrence MS, Stewart C, Carter SL, McKenna A, Rodriguez-Sanchez IP, Espinosa-Castilla M, Woie K, Bjorge L, Wik E, Halle MK, Hoivik EA, Krakstad C, Gabiño NB, Gómez-Macías GS, Valdez-Chapa LD, Garza-Rodríguez ML, Maytorena G, Vazquez J, Rodea C, Cravioto A, Cortes ML, Greulich H, Crum CP, Neuberg DS, Hidalgo-Miranda A, Escareno CR, Akslen LA, Carey TE, Vintermyr OK, Gabriel SB, Barrera-Saldaña HA, Melendez-Zajgla J, Getz G, Salvesen HB, Meyerson M.

Nature. 2014 Feb 20;506(7488):371-5. doi: 10.1038/nature12881. Epub 2013 Dec 25.

16.

MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors.

Peter M, Rosty C, Couturier J, Radvanyi F, Teshima H, Sastre-Garau X.

Oncogene. 2006 Sep 28;25(44):5985-93. Epub 2006 May 8.

PMID:
16682952
17.

Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression.

Gimenes F, Souza RP, de Abreu AL, Pereira MW, Consolaro ME, da Silva VR.

Arch Gynecol Obstet. 2016 Apr;293(4):857-63. doi: 10.1007/s00404-015-3870-3. Epub 2015 Aug 28.

PMID:
26315473
18.

Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines.

Lockwood WW, Coe BP, Williams AC, MacAulay C, Lam WL.

Int J Cancer. 2007 Jan 15;120(2):436-43.

19.

Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

Kloth JN, Oosting J, van Wezel T, Szuhai K, Knijnenburg J, Gorter A, Kenter GG, Fleuren GJ, Jordanova ES.

BMC Genomics. 2007 Feb 20;8:53.

20.

Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells.

Luft F, Klaes R, Nees M, Dürst M, Heilmann V, Melsheimer P, von Knebel Doeberitz M.

Int J Cancer. 2001 Apr 1;92(1):9-17.

Supplemental Content

Support Center